Overview of Vitiligo Research October - December 2014
- Vitiligo Screening Tool (VISTO) is a simple, cost-effective, self-administered tool to confirm vitiligo.
- Much lower prevalence of vitiligo and later disease onset among Taiwanese population is reported (0.064%).
- Serum BDNF may be linked to repeatedly reported association of vitiligo with psychiatric disorders.
- Unexpectedly, IL-2 and IL- 6 levels hint at different mechanism of pathogenesis of stress-induced vitiligo.
- Analogue of viral DNA can trigger melanocyte death, which hints at possible contribution of viruses to vitiligo onset.
- Simvastatin is showing potency to reverse and prevent vitiligo in an experimental mouse model.
- Topical latanoprost (prostaglandin F2-alpha analogue) can be used (alone or in combination with NB-UVB phototherapy) to induce repigmentation of vitiligo lesions
- Infrequent topical tacrolimus can be used as prophylactics to prevent relapse after successful repigmentation
- Based on results of study in mice, simvastatin emerges as a novel treatment for vitiligo, capable to prevent vitiligo onset and to reverse already manifested disease
- Ethnical difference in vitiligo prevalence and associated comorbidities profiles has been further confirmed.
- Level of reactive oxygen species in erythrocytes emerges as an indicator of vitiligo activity.
- Involvement of regulatory T-cell abnormalities in vitiligo pathogenesis is gaining more support.
This is a review of research results in the vitiligo field which were indexed in the PubMed database (www.ncbi.nlm.nih.gov/pubmed) for the period from October till December 2014. Retrieved records were manually checked for a relevance to and significance for the field of vitiligo research. Fifty one records were found to be relevant and of interest, and were included into this quarterly overview, under the following sections:
- Reviews & Comments
- Disease Management And Clinical Features
- Quality of life (QoL)
- Vitiligo triggers
- Case reports
- Understanding mechanisms of vitiligo pathogenesis
- Genetic studies
- Candidate biomarkers
- Mechanisms of treatments
- Methodological advancements
- Novel treatment modalities
- Clinical studies and trials
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
VITFriends Fundraising and Awareness Concert in Boston
Featuring: M.C. - Mary-dith Tuitt Jazz vocalist - Katani Summer Steel drum instrumentalist - Justin Petty Vocalist - Emily Orji and Dr. Victor Huan...30 April 2017 14:30, Salvation Army Kroc Center, 650 Du...
Vitiligo Walk-A-Thon in Fort Dallas
The annual Vitiligo Walkathon is organized by Dallas Fort Worth Vitiligo Support Group on May 20, 2017. This is an event held to raise awareness about vitiligo in the...20 May 2017 09:00, Dallas, Texas
Is vitiligo contagious?
Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting nex...
How long does it take to treat vitiligo?
Treatment results will vary by person and type of vitiligo. The rule of thumb is that you will need to allow at least 3 to 6 months before you begin to see results fro...
Isn't it just a cosmetic disorder?
Like it or not, we live in a society where appearance matters. It should come as no surprise that vitiligo impacts on the psychological well-being and quality of life ...
Who is prone to vitiligo?
Vitiligo affects 0.5-2% of the population, and occurs in all races and all social levels. Vitiligo can affect people of all ages, but often starts between the ages of ...